PAPAKOSTAS PAVLOS

profil

Chief of 2^nd Oncology Clinic at Metropolitan General

Coordinating Director of the Oncology Unit at the General Hospital of Athens Ippokrateio

EDUCATION & ACADEMIC DEGREES

I was born on 11/06/1953 in Arta, Ipeiros, where I completed my basic and intermediate education.

In 1972 I passed at the Medicine School of the University of Athens, from which I graduated on 6/2/1979 with “Very Good” grades.

I received my professional permit on 15/03/1979.

I received my specialty in Pathology on 13/01/1986 and the title of Professor of the Medicine School of the University of Athens with “EXCELLENT” grade (Thesis Diploma No. 1270), on 27/06/1989 and the title of Pathological Oncology specialty on 7/7/1999 (Prot. No.: 24802/99) immediately after this specialty was established in Greece.

WORK EXPERIENCE

Between 15.3.1979 and 15.3.1981 I served in the military as a Sergeant Doctor at the 251 General Hospital of Aviation (3 months) and at the Infirmary of the Tatoi air base
Between 27.6.1981 and 8.9.1982 I served at the State Hospital of Ioannina for rural area service, acknowledged as specialty in Pathology
Between 6.10.1982 and 1.1.1984 I served at IKA as a doctor
Between 24.12.1983 and 4.11.1985 I served at the Army Pension Fund Hospital (NIMTS) (1st Pathology Clinic) as an intern in Pathology
Between 9.1.1986 and 9.9.1986 I served at the 1st Infirmary of IKA as a Supervising Physician
Between 10/09/1986 and 9/4/1997 (10 years and 5 months) I served at the University Pathology Clinic of the Ippokrateio Hospital as a Second Supervising Physician, responsible for treating the clinic’s oncological patients and for the operation of our Hospital’s Oncology Practice. I was also involved in the training of interns, as we as students of the Medicine School of the University of Athens.
During this time, I was transferred between 1/2/1988 and 28/02/1989 and between 5/12/1990 and 5/12/ 1991 (a total of 25 months) and worked at the 3rd Pathological Oncology Clinic of Oncology Hospital “Oi Agioi Anargyroi” as a Supervising Physician, heading a department of 15 patients and involved in the operation of the short-term hospitalization department and outpatient department of the clinic
I was granted a further education leave by the National Health System and worked between 1/4/1995 and 31/3/1996 (12 months) at the Hammersmith Hospital of London, in the Oncology Department of the Royal Postgraduate Medical School. During this time, in addition to my daily involved in the Oncology Clinic clinical and educational work, I also worked as coordinator in transplantation protocols with peripheral progenitor blood cells, following high dosages of chemotherapy
I also worked at the Tumor Targeting Laboratory of the Imperial Cancer Research Fund, on research protocols using monoclonal antibodies for cancer treatment
Between 9/4/1997, when I occupied the position of First Supervising Physician specializing in Oncology and late 2002, I exercised duties of Director at the Oncology Department of the General Hospital of Athens Ippokrateio, assigned by the Hospital's BoD
Between 2003 and August 2018, I served as Coordinating Director of the Oncology Unit at the General Hospital of Athens Ippokrateio
Between September 2018 and to this day I have been working as Director of the 2nd Oncology Clinic of the Metropolitan General Hospital

PUBLICATIONS IN SCIENTIFIC JOURNALS

PARTICIPATION IN RESEARCH PROGRAMS

Between early 1984 and late 1985, I participated as a researcher in the NIMTS research team which, in cooperation with London's IMPERIAL CANCER RESEARCH FUND (ICRF), researched monoclonal antibodies and their applications in diagnosing and treating cancer.
During 1/4/95-31/3/96 I was in charge of a Research program for transplanting peripheral progenitor blood cells after high dosages of chemotherapy at the Hammersmith Hospital in London. During the same time, I was also involved in the Tumor Targeting Laboratory of the Imperial Cancer Research Fund, on research programs using monoclonal antibodies in diagnosing and treating cancer.
Since 1988 and to this day I have participated in dozens of research protocols, in several of which I was the coordinator in charge. Their results were announced and/or published in international or Greek acknowledged journals and conferences.
I am a member of the Hellenic Cooperating Oncology Group (HeCoG) Scientific Committee, which works on performing clinical and laboratorial studies. This group has completed a large number of phase I, II and III clinical studies, related to the entire spectrum of solid tumors, the results of which have been published in acknowledged international journals and have been announced in International and Greek conferences. In addition to being a member of this Group's Scientific Committee, I have also been in charge of planning, organizing and coordinating protocols related to cancers of the Gastrointestinal Tract. The Hellenic Cooperating Oncological Group was awarded for its Scientific and Research work by the Academy of Athens in December 2001.
I have participated as a researcher in several International multi-centric studies with permits by the EOF and my hospital's Scientific Committee and BoD.

PARTICIPATION IN SCIENTIFIC ASSOCIATIONS

PARTICIPATION IN SCIENTIFIC BODIES

Member of the Oncology Committee of the Central Health Council (KESY)
General Secretary of the Hellenic Scientific Society of Oncologists-Pathologists for two service periods (4 years)
President of the PET Committee of the Central Health Council (KESY)
President of the Scientific Committee of the General Hospital of Athens IPPOKRATEIO
Director of the Pathology Sector of the General Hospital of Athens IPPOKRATEIO
Member of the Committee for examinations in the Oncology-Pathology specialty (dep.)
Consulting Oncologist at the Oncology Councils of the following Hospitals:

-NIMTS: between 1.10.1986 and late 1990
-SISMANOGLEIO: between 1.1.1987 and 6.4.1995
-GENERAL HOSPITAL OF ATHENS IPPOKRATEIO: between 1.4.1997 and to this day

HONORARY DISTINCTIONS

Award presented by the Academy of Athens to the Hellenic Cooperating Oncological Group, of which I am a member, as well as a member of the Scientific Committee, for its Scientific and Research work in the treatment of cancer
First Scientific Paper Award during the 7th Pan-Hellenic Conference of Clinical Oncology for paper: “Comparison of paclitaxel plus carboplatin and paclitaxel with alternating platinum and carboplatin combinations as first line treatment for ovary cancer” Thessaloniki, April 4, 1998
First Scientific Paper Award during the 11th Pan-Hellenic Conference of Clinical Oncology for paper:
“Paclitaxel and CMF versus epirubicin and CMF in Patients with high-risk breast cancer”
Thessaloniki, April 6, 2002 (Cert. No. 32)

“Intensive consecutive chemotherapy with epirubicin”